COMPANY INSIGHT

Sponsored by Lenzing Plastics

A hidden champion for medical components out of PTFE

Our company name clearly indicates our location. Our headquarters and our research, development and production departments are located in Lenzing, Upper Austria. Made in Austria stands for innovative products of the highest quality and, at the same time, defines the self-image of Lenzing Plastics.

Production site in Austria, committed to quality

The company's manufacturing possibilities are second to none terms of quality and versatility. The integration of various production stages and processes offers unique possibilities

Unique worldwide, production versatility

In order to take full advantage of this machinery and system facility for the implementation of customer-specific product requirements, our research and development department works on the solutions of tomorrow. Our intensive development work is reflected in the fact that more than half of our active products are less than three years old

Tailor-made innovation, a focus on customer requirements

All of these factors allow us to react quickly and flexibly to a wide variety of requirements. We provide our customers with advice and assistance from the first stage of development to the finished product. Bundling all functions at one location and our centralized location in central Europe allow a fast, efficient approach. Our customers all over the world appreciate this.

Medical component manufacturing

Our product range for the Medical industry consist of yarns, fibers, films, tapes and tubes out of the unique polymer PTFE. We hold a certificate of ISO 13485 and manufacture in controlled environment and partly even in a certified cleanroom.


The PTFE components made by Lenzing Plastics are the basic materials for extremely smooth, soft and - above all - biocompatible textiles and implants.

Why use PTFE yarns, sutures or tubes/ films?

  • Extremely smooth: It is virtually impossible for deposits to adhere to PTFE. Suturescanbeeasilyremovedwithoutdamaging sensitive tissue
  • Extremely biocompatible: PTFE is chemically inert and it has been successfully used in longterm class 3 implants for decades
  • Extremely durable: PTFE is an extremely stable polymer that barely loses any of its strength and flexibility over many, many years

Applications for PTFE components:

Surgical suture: all over the world PTFE sutures with basic yarn from Lenzing Plastics are validated. PTFE surgical suture is often indicated for use in general soft tissue approximation and/or ligation, including dental, general surgical procedures and repair of the dura mater. Claims made by our customers include:

  • Ultra-smoth surface
  • Excellent security with snug and flattened knts
  • N memory
  • Reduced ptential for bacterial migration into the surgical site
  • Sft and comfortable for patients

Heart valve manufacturing: this area was the first application using Lenzing PROFILEN PTFE yarns nearly 20 years ago. At the beginning sewing rings of conventional valves were the first items, using the benefits of PTFE: extremely biocompatible, very smooth and very durable. Over the time also TAVI products needed the support of yarn out of PTFE. The very soft material is easy to compress and therefor perfect to reach the low profile necessary for crimping a device into the catheder.

Covered stents/ stent grafts: especially for smaller diameters of covered stents, PTFE is the material of choice. The flexibility of the material combined with the specific nonadherent surface are perfect for those applications. Lenzing Plastics can supply various PTFE components for manufacturing covered stents

Contact information

Lenzing Plastics

Volker Biladt (Sales Director):

v.biladt@lenzing-plastics.com

www.lenzing-plastics.com/en

Go to article: Home | Balancing function with fashionGo to article: In this issueGo to article: ContentsGo to article: Formacoat Company InsightGo to article: FormacoatGo to article: BioInteractions Company Insight Go to article: BioInteractions Go to article: BriefingGo to article: Industry newsGo to article: The medical industry briefingGo to article: Covid-19 executive briefing by GlobalDataGo to article: Omnitron Company Insight Go to article: Omnitron Go to article: CombinosticsGo to article: Watlow Company InsightGo to article: WatlowGo to article: FortisGo to article: CommentGo to article: Mobile health applications can help with cognitive function and mental healthGo to article: Digital therapeutics are not a panacea for the global mental health crisisGo to article: FDA authorises the first AI-based software to detect prostate cancerGo to article: Lenzing Plastics Company InsightGo to article: Lenzing PlasticsGo to article: AccumoldGo to article: On Line ControlsGo to article: SiemensGo to article: In DepthGo to article: Equipment aesthetics: the companies improving mobility aid designGo to article: Counterfeit medical devices: on the rise during Covid-19?Go to article: NuroKor Bioelectronics: can electricity replace opioids?Go to article: Paragonix: the next generation of donor organ transportGo to article: Can tech solve the UK radiology staffing shortage?Go to article: How hospitals and the medtech sector are tackling the climate crisisGo to article: HoowakiGo to article: Frankfurt Laser CompanyGo to article: ProByLas Go to article: Sandvik Company InsightGo to article: Sandvik Go to article: VartaGo to article: In DataGo to article: Data: North America is seeing a hiring boom in medical industry ESG rolesGo to article: The medical industry key listGo to article: Global markets and indicesGo to article: Macro-economic indicatorsGo to article: Macro-economic indicators (page 2)Go to article: Custom Wire Company Insight Go to article: Custom WireGo to article: RegPakGo to article: SemecsGo to article: oncgnosticsGo to article: EventsGo to article: Next Issue